Publications
Respiratory investigationApr 2024 |
62
(
4
),
582-588
DOI:
10.1016/j.resinv.2024.04.002

NECTIN2 is a prognostic biomarker and potential therapeutic target in lung adenocarcinoma

Ando, Takahiro; Ka, Mirei; Sugiura, Yuriko; Tokunaga, Masakatsu; Nakagawa, Natsuki; Iida, Takahiro; Matsumoto, Yoko; Watanabe, Kousuke; Kawakami, Masanori; Sato, Masaaki; Kage, Hidenori
Product Used
Genes
Abstract
NECTINs are transmembrane proteins mediating cell-to-cell adhesion. NECTINs interact with integrins or other membrane receptors to trigger multiple cellular functions. Aberrant NECTIN expression is associated with cancer progression and poor outcomes. While NECTIN2 is overexpressed in various cancer types, its role in lung cancer is not well understood.We investigated the function of NECTIN2 in lung adenocarcinoma (LUAD) using the Cancer Genome Atlas (TCGA) dataset and clinical samples of 105 LUAD patients who had undergone surgical resection. Cell proliferation, apoptosis, migration and invasion were investigated using human lung adenocarcinoma cell lines.We found that high NECTIN2 expression correlated with reduced overall survival in LUAD in TCGA database. In clinical samples, high NECTIN2 expression was associated with lower recurrence-free survival in all patients (P 
Product Used
Genes

Related Publications